Clinical Trial Update: Tamoxifen in Treating Patients With Primary Liver Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating tamoxifen for primary liver cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: National Medical Research Council (NMRC), Singapore | Conditions: Liver Cancer | Phase 3 | Status: COMPLETED